ALA arovella therapeutics limited

News: ALA Arovella Therapeutics Announces Sumatriptan Update

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    June 28 (Reuters) - Arovella Therapeutics Ltd (ALA) :

    • SUMATRIPTAN UPDATE-ALA.AX
    • STRIDES PHARMA GLOBAL INDICATED ITS INTENTION TO CEASE DEVELOPMENT, LICENCE AND SUPPLY DEAL ENTERED INTO 8 NOV 2018
    • HAS AGREED TO TERMINATE AGREEMENT
    • WILL RESTRUCTURE REFORMULATION GROUP TO MATCH REDUCED REQUIREMENTS FOR REFORMULATION PROJECT WORK
    • CO NOTES THAT THERE IS NO COST IMPACT TO AROVELLA OR IMMEDIATE IMPACT ON REVENUE STREAMS
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.5¢
Change
-0.001(1.04%)
Mkt cap ! $113.6M
Open High Low Value Volume
9.4¢ 9.5¢ 9.3¢ $96.74K 1.026M

Buyers (Bids)

No. Vol. Price($)
2 74010 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 100000 1
View Market Depth
Last trade - 16.10pm 18/09/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.